[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2024-2029 Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Assays, Strategic Profiles of Leading Suppliers

November 2024 | | ID: 254436C8A4C1EN
Venture Planning Group

US$ 3,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 280 pages and 6 tables 


More Publications